Dynamics of Venture Capital Funding in the Bio-based Chemicals Industry

September 29, 2014 | State of the Market Report

Following a drop in investment caused by the financial crisis, venture capital (VC) investment in bio-based materials and chemicals (BBMC) came back with a boom. VC investment rose steadily and reached a peak of $1.3 billion in 2011. However, the lackluster performances of both public and private BBMC companies led investors to place smaller bets in recent investment. In this report, we dig into investment in the tumultuous BBMC space, analyzing VC, corporate VC, initial public offering (IPO) activity, and acquisitions.

Coverage Area

  • Accelerating Materials Innovation

Table of Contents

  • Executive Summary
  • Landscape
    Equity investment in the BBMC space slumped following the 2008 global financial crisis; it recovered after 2009 and peaked at $1.3 billion in 2011.
  • Analysis
    Investors flock to a few main technologies and feedstocks; post-IPO companies struggle to increase their stock price, and acquisitions heat up.
  • Outlook
  • Endnotes

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978